Please login to the form below

Not currently logged in
Email:
Password:

respiratory disease

This page shows the latest respiratory disease news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

The new initiative aims to help countries to access affordable medicines to treat the major symptoms of COVID-19, including inflammation and respiratory problems linked to the disease. ... The ‘Novartis COVID-19 portfolio’ is comprised of 15

Latest news

  • Homesick Homesick

    susceptible are those with underlying co-morbidities like metabolic syndrome and cardiovascular disease. ... Of course, the respiratory patients – those with chronic obstructive pulmonary disease, bronchitis and asthma – are in the same boat as the

  • AstraZeneca forms $2bn gene silencing pact with Silence Tx AstraZeneca forms $2bn gene silencing pact with Silence Tx

    Collaboration focuses on cardiovascular, renal, metabolic and respiratory disease. UK biotech Silence Therapeutics has added to its growing stable of pharma partnerships with a wide-ranging collaboration with AstraZeneca in cardiovascular,

  • Germany's coronavirus infections climb but deaths remain low Germany's coronavirus infections climb but deaths remain low

    Currently, Germany has confirmed over 16, 000 cases of coronavirus infections among its citizens – the virus which causes the respiratory disease COVID-19.

  • COVID-19: Novel coronavirus remains stable on surfaces for hours COVID-19: Novel coronavirus remains stable on surfaces for hours

    Researchers have discovered that the novel coronavirus – which causes the respiratory disease COVID-19 – remains stable on surfaces for several hours to days.

  • UK ramps up measures to combat coronavirus spread UK ramps up measures to combat coronavirus spread

    The data showed that 30% of those who were hospitalised with the coronavirus – which causes the respiratory disease COVID-19 – were eventually admitted to intensive care. ... Although the case fatality ratio is significantly lower than SARS, the

More from news
Approximately 4 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • A snapshot of… Enterprise Therapeutics A snapshot of… Enterprise Therapeutics

    How is the company advancing research in respiratory disease? In healthy lungs, mucus lining the airways consists mainly of water (97% fluid, 3% solids), enabling it to capture and remove the ... In many respiratory diseases, however, the mucus becomes

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    joined the company in 2013 after a distinguished clinical career as Consultant Respiratory Physician at London Chest Hospital, Barts Health NHS Trust, in London, UK. ... COPD was a Cinderella disease when I started in respiratory medicine but it is

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    The novel coronavirus, which causes the respiratory disease COVID-19, has overwhelmed healthcare systems and led to strict lockdowns in countries across the world as governments fight to tackle the spread ... Infectious disease expert Lindsey R Braden

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease. ... Echoing James Roach’s sentiment, she said: “Please don't wait to be asked, but make sure you're coming to us

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Combine asthma with other respiratory diseases, including chronic obstructive pulmonary disease (COPD), and it contributes to more than 4 million deaths every single year, a stagnated figure that has seen no ... For innovation in respiratory medicine to

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’ experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech. ... Their expertise and counsel will broaden our base of leadership and support our mission to change the world for

  • Karus names two division heads Karus names two division heads

    Most recently he was VP, global head – respiratory disease. In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

  • Aurora expands its team with three new hires Aurora expands its team with three new hires

    Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and ... cardiovascular disease.

  • Oliver Rausch to lead translational research partnership efforts at NIHR Oliver Rausch to lead translational research partnership efforts at NIHR

    Efforts currently cover two areas, inflammatory respiratory disease and joint and related inflammatory diseases, both of which shall be overseen by Dr Rausch.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Understanding COVID-19 and varying responses across the globe

    other countries through the international spread of disease requiring a coordinated international response. ... Despite these strategies, the disease spread across the world at an alarming rate.

  • What role for pharma in helping to deliver integrated care?

    In common with all Sustainability and Transformation Partnerships (STPs), ICSs have certain areas that they must focus on under the Long Term Plan, such as diabetes, cancer and respiratory disease.

  • Ben Hwang discusses innovative diagnostic real-time monitoring data-sensors

    Ben Hwang, MA, PhD, Chairman and CEO of Profusa, a company innovating in diagnostics and real-time disease monitoring, talks to us about how continuous data sensors could transform the way ... Profusa have recently received approval for their first

  • Exploring MINT: Part 2 - Indonesia

    Interestingly, the younger age profile does give the country a different disease profile to that of ‘older’ nations. ... Air pollution in urban areas is responsible for a high burden of respiratory disease.

  • Say Communications Say Communications

    Patient advocacy, NHS relations and stakeholder engagement. Disease awareness and public health programmes. ... Public health and disease prevention. Respiratory disease. Rare diseases. Rheumatology. Men's health.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics